Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2221 AL 2235

[Molecular Biological Aspects of Depressive Disorders: A Modern View]

Ushakova VM, Morozova AY, Reznik AM, Kostyuk GP, Chekhonin VP.

Mol Biol (Mosk). 2020 Sep-Oct;54(5):725-749. doi: 10.31857/S0026898420050110.

[Relationship between Type I and Type II Template Processes: Amyloids and Genome Stability]

Andreychuk YV, Zadorsky SP, Zhuk AS, Stepchenkova EI, Inge-Vechtomov SG.

Mol Biol (Mosk). 2020 Sep-Oct;54(5):750-775. doi: 10.31857/S002689842005002X.

Sequence and structure-based peptides as potent amyloid inhibitors: A review

Mitra A, Sarkar N.

Arch Biochem Biophys. 2020 Nov 30;695:108614. doi: 10.1016/j.abb.2020.108614. Epub 2020 Sep 30.

Mindfulness, Stress, and Aging

Felsted KF.

Clin Geriatr Med. 2020 Nov;36(4):685-696. doi: 10.1016/j.cger.2020.06.010. Epub 2020 Aug 17.

Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of Patients

Ahlskog JE.

Mayo Clin Proc. 2020 Oct;95(10):2225-2234. doi: 10.1016/j.mayocp.2020.02.006.

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease

Rideout HJ, Chartier-Harlin MC, Fell MJ, Hirst WD, Huntwork-Rodriguez S, Leyns CEG, Mabrouk OS, Taymans JM.

Front Neurosci. 2020 Aug 18;14:865. doi: 10.3389/fnins.2020.00865. eCollection 2020.

The Dual Nature of Onuf's Nucleus: Neuroanatomical Features and Peculiarities, in Health and Disease

Schellino R, Boido M, Vercelli A.

Front Neuroanat. 2020 Sep 4;14:572013. doi: 10.3389/fnana.2020.572013. eCollection 2020.

Editorial: Non-Dopaminergic Systems in Parkinson's Disease

Miguelez C, De Deurwaerdère P, Sgambato V.

Front Pharmacol. 2020 Sep 11;11:593822. doi: 10.3389/fphar.2020.593822. eCollection 2020.

Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease

Galet B, Cheval H, Ravassard P.

Front Neurol. 2020 Sep 4;11:1005. doi: 10.3389/fneur.2020.01005. eCollection 2020.

Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

Mallah K, Couch C, Borucki DM, Toutonji A, Alshareef M, Tomlinson S.

Front Immunol. 2020 Sep 10;11:2021. doi: 10.3389/fimmu.2020.02021. eCollection 2020.

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases

Jiao F, Gong Z.

Oxid Med Cell Longev. 2020 Sep 14;2020:6782872. doi: 10.1155/2020/6782872. eCollection 2020.

The Significance of 8-oxoGsn in Aging-Related Diseases

Zhang X, Li L.

Aging Dis. 2020 Oct 1;11(5):1329-1338. doi: 10.14336/AD.2019.1021. eCollection 2020 Oct.

The Golgi Apparatus May Be a Potential Therapeutic Target for Apoptosis-Related Neurological Diseases

He Q, Liu H, Deng S, Chen X, Li D, Jiang X, Zeng W, Lu W.

Front Cell Dev Biol. 2020 Aug 31;8:830. doi: 10.3389/fcell.2020.00830. eCollection 2020.

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons

Fouka M, Mavroeidi P, Tsaka G, Xilouri M.

Front Cell Dev Biol. 2020 Sep 4;8:559791. doi: 10.3389/fcell.2020.559791. eCollection 2020.

Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology

Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P.

Front Cell Dev Biol. 2020 Sep 8;8:573696. doi: 10.3389/fcell.2020.573696. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias